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Summary: The total and Ultrafiltrable citrate of serum were measured in healthy controls, and in patients with
calcium-containing kidney stones classified into the various calciuria types (normocalciuria, renal, absorptive,
resorptive hypercalciuria). The total citrate in two subgroups (normocalciuria, renal hypercalciuria) was significantly
higher than in controls. Two independent analyses showed a mean Ultrafiltrable fraction of 0.86 (controls and stone
formers, with the exception of resorptive hypercalciuria) and 0.95 (resorptive hypercalciuria), i.e. the calculated
extent of binding of citrate to serum macromolecules (> 10000 Daltons). The differences in the fraction of free
citrate between controls and renal stone formers are not sigriificant. The apparent mean association constants are
(1/mol) 0.24 X l O2 (controls) and 0.29 X l O2 (noimocalciuria). There is a high correlation between the ultra-
filtrable fraction and total citrate in the serum, and also between the ratlos urinary/serum creatinine and urinary/
serum total citrate, during a 2 h endogenous creatinine clearance in the morning (fast in g). These findings suggest that
1) there is citrate binding in the serum,
2) the normal portion of free citrate in total serum citrate of normocalciuric stone formers cannot explain the
decreased citrate excretion in 24 h urine of these subjects,
3) under defined conditions of examination (morning;fasting) urinary citrate is determined largely by the filtered
load of citrate in the proximal renal tubüle.
Ultrafiltrierbares Citrat im Serum und Beziehungen zwischen Serum- und Urincitrat:
Ergebnisse bei Gesunden und Untergruppen der Calcium-Ürolithiasis
Zusammenfassung: Im Serum wurden Gesamt- und Ultrafiltrierbares Citrat bei gesunden Kontrollpersonen sowie
Patienten mit calciumhaltigen Nierensteinen, unterteilt in die verschiedenen Calciurie-Typen (Normocalciurie, renale,
absorptive, resörptive Hypercalciurie)* gemessen. Das Gesamt-Citrat in zwei Untergruppen (Normocalciurie, renale
Hypercalciurie) ist signifikant höher als bei Gesunden. Unter Verwendung zweier unabhängiger Analysen fand sich
eine mittlere ultrafiltrierbare Fraktion zwischen 0.86 (Kontrollen; Steinbüdner, ausgenommen resorptive Hypercalci-
urie) und 0,95 (resorptive Hypercalciurie), d.h. eine errechnete Citratbindung an Serum-Makromoleküle (> 10 000
Daltons). Die Unterschiede im Anteil des freien Citrats zwischen Kontrollen und Hamsteinkranken sind nicht signi-
fikant. Die scheinbaren mittleren Assoziationskonstanten sind (1/mol) 0,24 X l O2 (Kontrollen) und 0,29 X l O2
(Normocalciurie). Es besteht eine hohe Korrelation zwischen der ultrafiltrierbaren Fraktion und dem Gesamt-Citrat
im Serum, sowie eine ausreichend hohe zwischen den Quotienten Urin/Serum-Kreatinin und Urin/Serum-Gesamt-
Citrat während einer 2 h endogenen Kreatinin-Clearance am Morgen (nüchtern). Diese Befunde erlauben die Annahme,
daß
1) eine Citratbindung im Serum vorliegt,
2) der normale Anteil von freiem Citrat am Gesamt-Citrat im Serum bei Steinkranken mit Normocalciurie nicht das
bei diesen niedrigere Citrat im Tagesurin erklären kann,
3) unter definierten Untersuchungsbedingungen (morgens, nüchtern) Urin-Citrat weitgehend von der Citratbelastung
des Primärharns bestimmt wird.
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Introduction
Citrate is considered an important chelator of cations
such äs calcium and magnesium in biological Systems
like bone and urine. In the latter milieu it reduces the
concentration of free calcium ions available for nuclea-
tion with phosphate and oxalate (l, 2). Therefore, the
inhibitory activity of citrate with respect to stoneforming
processes led investigators to search for abnonnalities of
citrate metabolism in renal stone disease.
In a previous (3) and an accompanying (4) study we have
been able to demonstrate that, in the absence of primary
hyperparathyroidism, urinary citrate excretion during a
2 h morning clearance period is not different fröm con-
trols in patients with recurrent idiopathic calcium and
uric acid stone formation, although at the same time
serum citrate is elevated in stone formers äs a whole.
This observation prompted the present investigätion
into possible differences in the citrate fraction freely
filtrable at the glomerular level in subgroups of
calcium lithiasis, since such a phenomenon might be at
least a partial explanation for differences in urinary
citrate excretiori.
Subjects and Methods
A total of 36 healthy controls (d/9 = 20/16) from the hospitäl
staff (22-69 years; median 40) and 74 non-acidotic patients
(d/9 = 44/30) with metabolically active recurrent renal calcium
stone formation (20—71 years; median 46) were studied whüe
on their usual home diet. The renal function was normal (serum
creatinine < 13 mg/1; endogenous creatinine clearance > 60 ml/
min) in all subjects, and no other serious ülnesses were detectable
at the time of examination. Following a 12^15 h overnight fasting
period at home, antebrachial venous blood was drawn anaerobic-
ally into 5 ml-vacutainers without additive (Becton-Dickinson;
Hamburg) at 8 a.m. in the laboratöry with subjects seated. Gare
was taken not to apply stasis to the blood vessel after hiaving
punctured it. Then diuresis was stimuläted by the administration
of 2 X 300 ml tap water, and a 2 h clearance period started after
bladder voiding. The urinary calcium/creatinine ratio iii this
period and its response to a test meal in a subsequent 3 h col-
lection period permitted classification of the patients into the
various calciurias (normocalciuria, absorptive, renal leak, bone
resorptive1) hypercalciuria) (5,6). The study of serum citrate
fractions was restricted to a limited number of controls (n = 13;
<5/9 = 9/4), normocalciuria (n = 13; d/9 = 10/3), absorptive
(n = 2; c5/9 - 0/2), renal (n = 7; d/9 = 3/4), resorptive (n = 5;
<J/9 = 2/3) hypercalciuria.
Technique for determination of ultrafiltrable citrate: to 2 ml of
fresh anaerobically handled serum (second 3 ml vacutainer)
[l,5-14C]citrate (Radiochemical Centre Amersham; England),
appr. 1111-1295 Bq (30-35 nCi), was added and the mixture
allowed to stand for at least 15 min at room temperature.
Thereafter it was transferred to a pre-washed (0.15 mol/1 Nad)
yisking tube (< 10000 Daltons; Serva, Heidelberg), which was
immediately knotted and inserted into a specially manufactured
glass centrifuge tube (7) which was then tightly stoppered. This
tube was spun for 3 h at 3 000 min'1 and 37 °C in a prewarmed
JA-21 B (Beckman, Palo Alto) refrigerating centrifuge. The
System keeps sample pH below 7.50. Citrate (cold; radio-
actiye) and total protein were measured in both the ultra-
füträte and the supernatant.
l) Resorptive hypercalciuria is synonymous with verified primary
hyperparathyroidism.
In addition urinary citrate (2 h morning, 24 h urine), creatinine
(2 h urine oniy), and serum citrate, creatinine, inorganic phos-
phate and free fatty acids, were determined in groups of con-
trols and normocalciuric stone patients (for number of obser-
vations see results).
Analyses and calculations
Creatinine was measured by a Technicon-Autoanalyzer, phos-
phate by a micrpmethod (8), free fatty acidS by micro-titri-
metry (9), total protein by refractornetry, J14CJcitrate radio-
activity in a BF-5000 (Berthold; Wüdbad) liquid scintillation
spectrophotometer using 10 ml Unisolve Cocktail (Zinsser;
Frankfurt) per sample (50 ). The citrate lyase method äs
origjnally described (10) was used for citrate determination
in perchlöric acid (0.6 mol/1) extracts of serum (l ml serum
+ 2 ml perchlöric acid), whüe in order to achieve quantitative
citrate measurement in urine (pH 5.0-7.8) the sample was
pre-titrated (0.1 iriöl/1 NäOH) to pH 8.5 (citratelyase pH
pptimum: 8.2-8.6). Precision (CV%) was 2.74 (serum) and
1.23 (urine) in repeat determinatipns (n = 8-10) of a given
sample (= intraassay CV). Recovery (%) of citrate added to
serum was 97 ± 7.1 (SD), 99.3 ± 3.9 (dilution f^ctors in serum
extracts), 99.9 ±1.7 (citrate added to urine), 1ÖÖ.1 ± 0.6
(dilution factors in urine), consistent with an overall (0.4—25
nmolA) complete citrate recovery of 100.0 ±1.2%.
Compaiability of citrate concentration in ultrafiltrate and
serum necessitates corrections for the unit pläsma water (11)
allowing for protein volume (serum) pr content of solutes
(ultrafiltrate, Donnan factor .05). All results are expressed
äs means with l Standard error of the mean. Significance of
differences was set at the 5 per cent probability level
(Studenfs tatest).
Results and Corriments
Totaland ultrafiltrable citrate of serum (tab. 1)
Total citrate in eontrols was in'the ränge reported by
others (12) and ourselves (4), using the same method,
and the higher mean valties in renal stone disease (4)
were confirmed. For the first time, to our knowledge,
the table provides data on ultrafiltrable citrate obtained
with two different analytical methods (enzymatic;
radioactivity-related).
The validity of the ultrajSltratipn prpcedüre häs been
demonstrated: according to the conceptual model of
Ultrafiltration oütliried by Terepka et aL (l 1) the protein
concentration remaining in the supernatant after centri-
fugation increases, while the concentration of the ligand
under study decreases (so-called.Sandwich subtraction).
For both citrate and [*4C]citratej Üiese two important
criteria are fulfilled. If we consider the technique used
to be acceptable, there still remains a fraction of serum
citrate that escapes Ultrafiltration, and which might be
bound to serum macrpmolecules (> 10000 Daltons).
The fraction of ultrafiltrable citrate varies between 0.86
(controls, normocalciuria, absorptive, renal hypercalci-
uria) and 0.95 (resorptive hypercalciuria), while with
[14C]citrate it varies betweeri 0.93 (controls, normo-
calciuria, absorptive hypercalciuria) and 0.96 (renal,
resorptive hypercalciuria).
Only one significant difference is found when we com-
päre the fractions of free citrate obtained with either
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method and this is seen in the normocalciuria. Thus,
in this group the rather larger free fraction of [14C]-
citnite may reflect a non-optimal incubation procedure.
Non-covalent binding is time-dependent and the chosen
period may have been somewhat too short to allow
maximal binding. From the stable specific activity in
the original and the pertinent ultrafiltrate samples
(all groups) there is evidence, however, that citrate
and [14C] citrate behave identically when exposed to
the membrane.
Factor^ related to citrate binding
Provided that incomplete ultrafilterability of serum
citrate is confirmed by other laboratories, considera-
tion of factors associated with this phenomenon would
be worthwhile. Other anions in the serum which are
known to manifest partial binding, e.g. phosphate, free
fatty acids, and urate, may compete with citrate for
binding sites.
This partial binding is less (phosphate; see below),
similar (urate (7)) or greater (free fatty acids; see below).
However, the present work shows that the fraction of
free citrate, and hence that of bound citrate in stone
disease does not differ significantly from that of con-
trols.
This seems remarkable in view of the serum concentra-
tion of the above constituents in normocalciuria
(accounting for approx. 60 percent of all calcium stone
formers), which is lower (phosphate; tab. 2) or higher
(free fatty acids; tab. 2) than normal, while urate is un-
changed (not shown). Assuming a normal serum albumin
concentration (45 g/l) and a single class of binding sites
in controls and normocalciuria we calculated, in accord-
änce with Goldstein2 (13), the following approximate
apparent association eonstants (1/mol), äs based on the
mean fraction citrate bound, which had been extra-
polated from the mean ultrafiltrable fraction: controls
K = 0.24 X 102, nqnriocalciuriä K = 0.29 102.
Although these values would fall within the ränge of
urate binding (K = 0.6 102 (7,14)) they are higher
than for phosphate (K = 1.5 X IQ1 approx. (15)), and
much lower than for free fatty acids (K = l. l X l O7
approx. (16)). Thus normal fractions of free and bound
citrate in normocalciuric stone formers is an unexpected
finding. One can only speculate äs to whether differ-
ences in affinity of individual free fatty acids to binding
sites or, alternatively, the available number of binding
sites, account for this finding.
The relationship between serum and urinary citrate
The manner in which citrate arriving in the glomemlar
ultrafiltrate is handled by the human kidney is largely
2) using the formula: fraction bound (inol/1) = n X K X [PJ,
where n is the number of binding sites, [P] serum albumin
( / = 65 000) concentration, K association constant.
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Tab. 2. Serum concentration of citrate, phosphate, free fatty acids, and citrate Output in 2 h fasting and 24 h urine of controls and
normocalciuric renal calcium stone formers. Means ± SEM.
Controls
(m)
Normocalciuria
(n)
Serum
Citrate
( / )
109 ±4
(34)
126 ± 4C
(59)
Phosphate
(mmol/1)
1.22 ± 0.03
(36)
1.02 ±0.02°
(61)
Free fatty acids
(mmol/1)
0.405 ± 0.03
(30)
0.695 ± 0.0496
(27)
Urine
Citrate
(ßmoi/2 h)
217 ± 21
(31)
234 ± 17
(58)
Citrate
(mmol/24 h)
2.78 ± 0.13
(3f6)
2.25 ± 0.16b
(59) .
b
 p < 0.01
c
 p < 0.001
vs controls
unknown. If citrate excreted in urine were determined
mainly by the filtered load of citrate in the early
proximal tubule a rather close coupling of urinary
citrate excretion and the filtered load (= prpduct of
endogenous creatinine clearance and free serum citrate)
of citrate would be expected, äs in the case of substances
which either are bnly filtered (e.g. endogenous creatinine)
or are not reabsorbed in substantial amounts beyond the
proximal tubule (e.g. phosphate). In the case of unaltered
endogenous creatinine clearance in calcium stone formers,
a fact well documented, the filtered load of citrate to the
proximal tubule would be dependent mainly on free
citrate in the serum. We found that the latter and total
serum citrate are highly correlated in controls and normo-
calciuric stone forming individuals (r = 0.974 and
r = 0.932 respectively) who participated in our ultra-
filtration study (tab. 1). These facts lead us to hypothe-
size that free and bound serum citrate can be predicted
from the ratio of the concentrations of creatinine in the
urine and serum, and from urinary citrate, provided that
there is a sufficiently high correlation between this ratio
of both substances. This is recognisably the case in the
two groups (controls; normocalciuria) shown in figure l.
It seems therefore, that under the present conditions of
examination in the laboratory (morning endogenous
creatinine clearance following an overnight fast) urinary
citrate is in fact governed by the glomerular filtration
rate and serum citrate. The significance of this for
practical work is that routine measurements of urinary
creatinine and citrate, together with serum creatinine,
yield relatively accufate Information on the state of
serum citrate.
From the above, the unchanged fraction of ultra-
fdtrable serum citrate (tab. 1) and the normal urinary
citrate excretion in all groups during a 2 h fasting period
(tab. 2), it is clear however, that there is a net tubular
reabsorption of citrate during health (renal citrate
clearance is approx. 10-15 ml/min), but considerably
enhanced citrate reabsorption in calcium stone disease.
If statte serum citrate is assumed, citrate reabsorption
in calcium stone disease may be further exaggerated
during a 24 h daily cycle and thereby help to create
the now recqgnized deficiency in urinary Qitrate of
normocalciuric stone-forming individuals (tab. 2;
I.e. 3,4)). In conclusion, these considerätions riiäy help
to further the understanding of citrate metabolism and
to focus citrate research in calcium stone disease on the
kidney.
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Fig. 1. Relationship between citrate and urine/serum creatinine
in controls (·) and normocalciuric calcium stone formers
(x).
Regression equations:
1. controls
y = 0.457 + 0.091 , r = 0.768, n = 25, p < 0.001
( = regression line)
2. normocalciuria
y = 0.356 + 0.10 x, r = 0.773, n = 56,.p < 0.001
( = regression line).
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